CCM
BRNS

CAAS Capital Management’s Barinthus Biotherapeutics BRNS Stock Holding History

CAAS Capital Management’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,251
Closed -$161K – 466
2021
Q3 		$161K Sell
10,251
-39,749
-79% -$624K ﹤0.01% 421
2021
Q2 		$839K Buy
+50,000
New +$839K 0.01% 336